hiv ctl mep
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2004 (NCT00076037)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, passive
Human immunodeficiency virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv ctl mep
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00195234 | Phase 1 | Dec 1, 2004 | Pfizer, Wyeth |
| NCT00076037 | Phase 1 | Apr 1, 2004 | National Institute of Allergy and Infectious Diseases (NIAID), Vanderbilt University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 2004 |
| Pfizer | For profit | 1 | 1 | 1 | 2004 |
| Vanderbilt University | Academic/Hospital | 1 | 0 | 1 | 2004 |
| Wyeth | For profit | 1 | 0 | 1 | 2004 |
4 organizations
Page 1 / 1